METHOTREXATE

METHOTREXATE was reported 487634 times

METHOTREXATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 292 0.8690
1 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 5929 0.8267
2 RHEUMATOID FACTOR POSITIVE 4560 0.7887
3 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 518 0.7754
4 SWOLLEN JOINT COUNT INCREASED 2460 0.7707
5 PEMPHIGUS 9033 0.7218
6 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 1658 0.7190
7 RHEUMATIC FEVER 3208 0.7190
8 SYNOVITIS 12408 0.6875
9 LUPUS VULGARIS 865 0.6865
10 C-REACTIVE PROTEIN ABNORMAL 4353 0.6779
11 DEEP VEIN THROMBOSIS POSTOPERATIVE 1352 0.6750
12 DUODENAL ULCER PERFORATION 4952 0.6652
13 HAND DEFORMITY 8529 0.6496
14 C-REACTIVE PROTEIN 599 0.6462
15 GRANULOMA SKIN 497 0.6054
16 FACET JOINT SYNDROME 1943 0.5962
17 RHEUMATOID NODULE 1544 0.5600
18 X-RAY ABNORMAL 965 0.5391
19 BONE EROSION 1872 0.5288
20 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1089 0.5251
21 DISLOCATION OF VERTEBRA 1175 0.5147
22 BODY HEIGHT BELOW NORMAL 327 0.5086
23 MUSCLE INJURY 4206 0.5071
24 HELICOBACTER INFECTION 5134 0.4990
25 SERONEGATIVE ARTHRITIS 549 0.4791
26 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 3094 0.4759
27 FOLLICULITIS 4906 0.4674
28 RETINITIS 781 0.4517
29 CONTRAINDICATED PRODUCT ADMINISTERED 13309 0.4391
30 ENTHESOPATHY 684 0.4371
31 RHEUMATOID LUNG 406 0.4251
32 DACTYLITIS 407 0.4145
33 PERICARDITIS 6641 0.3949
34 PERIPHERAL VENOUS DISEASE 1605 0.3926
35 BLOOD PRESSURE DIASTOLIC ABNORMAL 981 0.3853
36 JOINT DESTRUCTION 597 0.3837
37 BLOOD PARATHYROID HORMONE DECREASED 562 0.3790
38 BLOOD PRESSURE SYSTOLIC ABNORMAL 936 0.3783
39 GLOSSODYNIA 8477 0.3783
40 LYMPHOPROLIFERATIVE DISORDER 1079 0.3670
41 DRUG TOLERANCE DECREASED 1026 0.3650
42 JUVENILE IDIOPATHIC ARTHRITIS 866 0.3538
43 RED BLOOD CELL SEDIMENTATION RATE INCREASED 3880 0.3503
44 TENOSYNOVITIS 965 0.3495
45 DRUG CLEARANCE DECREASED 449 0.3435
46 RHEUMATOID ARTHRITIS 38943 0.3426
47 ACUTE GRAFT VERSUS HOST DISEASE 1518 0.3313
48 CHRONIC GRAFT VERSUS HOST DISEASE 1173 0.3246
49 HYPOFIBRINOGENAEMIA 313 0.3155
50 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 558 0.3154
51 BLOOD IRON ABNORMAL 308 0.3153
52 GRIP STRENGTH DECREASED 2767 0.3141
53 SYSTEMIC LUPUS ERYTHEMATOSUS 10877 0.3061
54 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 843 0.3047
55 PANNICULITIS 731 0.3018
56 ARTHRODESIS 307 0.3016
57 JOINT RANGE OF MOTION DECREASED 4024 0.2997
58 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 408 0.2887
59 FINGER DEFORMITY 1398 0.2883
60 WOUND 8013 0.2864
61 HISTOPLASMOSIS DISSEMINATED 416 0.2620
62 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 337 0.2559
63 PSORIATIC ARTHROPATHY 10215 0.2514
64 CENTRAL NERVOUS SYSTEM LYMPHOMA 343 0.2487
65 ARTHROPATHY 13520 0.2430
66 BREAST CANCER STAGE III 1551 0.2392
67 BURSITIS 2880 0.2371
68 IRRITABLE BOWEL SYNDROME 5024 0.2341
69 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 495 0.2324
70 FOOT DEFORMITY 2544 0.2293
71 THERAPEUTIC PRODUCT EFFECT DECREASED 10178 0.2270
72 ONYCHOMADESIS 953 0.2269
73 POLYARTHRITIS 1172 0.2221
74 FIBROMYALGIA 5333 0.2191
75 LEUKOENCEPHALOPATHY 811 0.2175
76 WOUND INFECTION 2380 0.2171
77 DRUG SPECIFIC ANTIBODY 296 0.2161
78 LIP DRY 1943 0.2137
79 ONYCHOMYCOSIS 936 0.2131
80 MYELOPATHY 403 0.2120
81 GRAFT VERSUS HOST DISEASE IN SKIN 463 0.2100
82 FEBRILE BONE MARROW APLASIA 893 0.2099
83 HYPERCHOLESTEROLAEMIA 2024 0.2094
84 DRUG INTOLERANCE 20040 0.2072
85 JOINT ARTHROPLASTY 361 0.2015
86 SACROILIITIS 375 0.1985
87 PORPHYRIA ACUTE 284 0.1979
88 C-REACTIVE PROTEIN INCREASED 7179 0.1971
89 PSEUDOMONAL SEPSIS 344 0.1962
90 IMPAIRED HEALING 6446 0.1961
91 JOINT EFFUSION 1326 0.1921
92 CYTOMEGALOVIRUS CHORIORETINITIS 369 0.1890
93 JOINT SWELLING 22822 0.1889
94 SCLERITIS 299 0.1865
95 VENOOCCLUSIVE LIVER DISEASE 909 0.1839
96 SYNOVIAL CYST 849 0.1837
97 PULMONARY FIBROSIS 3511 0.1828
98 ANTIBODY TEST POSITIVE 303 0.1824
99 TUBERCULIN TEST POSITIVE 460 0.1815
100 OSTEOARTHRITIS 7687 0.1811
101 GRAFT VERSUS HOST DISEASE 1298 0.1803
102 TREATMENT FAILURE 14913 0.1798
103 PUSTULAR PSORIASIS 618 0.1798
104 LIMB DEFORMITY 284 0.1786
105 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 453 0.1754
106 HUMAN HERPESVIRUS 6 INFECTION 325 0.1718
107 LEUKAEMIA RECURRENT 290 0.1714
108 ARTHRITIS BACTERIAL 701 0.1706
109 LOWER RESPIRATORY TRACT INFECTION 7719 0.1696
110 EXOSTOSIS 1539 0.1684
111 AUTOIMMUNE DISORDER 1598 0.1638
112 LIVE BIRTH 1360 0.1624
113 HEPATIC ENZYME INCREASED 11030 0.1616
114 INFUSION RELATED REACTION 10647 0.1605
115 DISSEMINATED TUBERCULOSIS 412 0.1604
116 MUCOSAL INFLAMMATION 4186 0.1597
117 EPSTEIN-BARR VIRUS INFECTION 993 0.1588
118 LIVER INJURY 3853 0.1568
119 SCIATICA 2481 0.1555
120 ALANINE AMINOTRANSFERASE ABNORMAL 326 0.1544
121 NAIL DISORDER 1350 0.1541
122 BLOOD PRESSURE DIASTOLIC DECREASED 1138 0.1540
123 VENOOCCLUSIVE DISEASE 383 0.1528
124 KNEE ARTHROPLASTY 3204 0.1520
125 CYSTITIS HAEMORRHAGIC 612 0.1517
126 HIP ARTHROPLASTY 2324 0.1516
127 MUSCULOSKELETAL STIFFNESS 13272 0.1513
128 PNEUMOCYSTIS JIROVECI PNEUMONIA 337 0.1511
129 BLEPHAROSPASM 949 0.1506
130 LATENT TUBERCULOSIS 315 0.1503
131 ADENOVIRUS INFECTION 436 0.1502
132 CYTOMEGALOVIRUS INFECTION REACTIVATION 658 0.1488
133 LUPUS-LIKE SYNDROME 1341 0.1477
134 JOINT STIFFNESS 3836 0.1461
135 OBESITY 2279 0.1429
136 HISTIOCYTOSIS HAEMATOPHAGIC 423 0.1423
137 PULMONARY TUBERCULOSIS 603 0.1410
138 FAECAL CALPROTECTIN INCREASED 445 0.1404
139 DIFFUSE LARGE B-CELL LYMPHOMA 1079 0.1399
140 ASPERGILLUS INFECTION 917 0.1396
141 INFLAMMATION 7184 0.1391
142 STOMATITIS 8378 0.1380
143 BLOOD PRESSURE DIASTOLIC INCREASED 637 0.1379
144 SPINAL STENOSIS 568 0.1375
145 HEPATIC FIBROSIS 470 0.1368
146 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 301 0.1364
147 PNEUMOCYSTIS JIROVECII PNEUMONIA 1366 0.1359
148 SHOULDER ARTHROPLASTY 366 0.1358
149 SWELLING 12682 0.1354
150 CYTOMEGALOVIRUS VIRAEMIA 601 0.1350
151 SKIN NECROSIS 700 0.1348
152 NODULE 1751 0.1340
153 CUSHINGOID 430 0.1338
154 LIVER FUNCTION TEST INCREASED 2875 0.1338
155 CHONDROPATHY 361 0.1332
156 B-CELL LYMPHOMA 451 0.1326
157 JOINT DISLOCATION 1392 0.1315
158 ANKYLOSING SPONDYLITIS 1715 0.1300
159 DEMYELINATION 530 0.1292
160 TYPE 2 DIABETES MELLITUS 4347 0.1290
161 INFLAMMATORY MARKER INCREASED 632 0.1274
162 BK VIRUS INFECTION 425 0.1259
163 BASAL CELL CARCINOMA 1965 0.1258
164 UVEITIS 1697 0.1250
165 SARCOIDOSIS 593 0.1247
166 FINE MOTOR SKILL DYSFUNCTION 360 0.1243
167 MOUTH ULCERATION 2611 0.1238
168 ARTHRITIS INFECTIVE 574 0.1236
169 INFUSION SITE REACTION 368 0.1231
170 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 287 0.1208
171 BLOOD PRESSURE SYSTOLIC INCREASED 2359 0.1208
172 SPONDYLITIS 439 0.1206
173 WALKING AID USER 785 0.1189
174 DERMATOMYOSITIS 300 0.1183
175 SENSITIVITY TO WEATHER CHANGE 616 0.1170
176 DISCOMFORT 7107 0.1164
177 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1106 0.1158
178 ANTINUCLEAR ANTIBODY POSITIVE 375 0.1153
179 ARTHRITIS 9049 0.1149
180 MOBILITY DECREASED 8255 0.1148
181 PNEUMONIA VIRAL 366 0.1147
182 INJECTION SITE HAEMATOMA 1663 0.1145
183 MUSCULOSKELETAL PAIN 5925 0.1130
184 MUCORMYCOSIS 292 0.1123
185 MATERNAL EXPOSURE TIMING UNSPECIFIED 421 0.1120
186 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 5361 0.1115
187 BLOOD CULTURE POSITIVE 332 0.1108
188 BLISTER 6186 0.1100
189 PANCYTOPENIA 6076 0.1086
190 FOOT OPERATION 538 0.1086
191 BODY TEMPERATURE DECREASED 1064 0.1080
192 BRONCHIECTASIS 728 0.1079
193 SINUSITIS 10959 0.1068
194 BLOOD CHOLESTEROL INCREASED 4983 0.1068
195 BACK INJURY 1160 0.1066
196 BLOOD PRESSURE FLUCTUATION 2547 0.1060
197 IMMUNOSUPPRESSION 936 0.1060
198 STAPHYLOCOCCAL SEPSIS 523 0.1058
199 GAIT INABILITY 3526 0.1054
200 JOINT LOCK 298 0.1049
201 FEBRILE NEUTROPENIA 6945 0.1046
202 GRANULOMA 361 0.1042
203 PULMONARY TOXICITY 735 0.1038
204 ACUTE LYMPHOCYTIC LEUKAEMIA 290 0.1023
205 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 766 0.1020
206 IMMUNODEFICIENCY 1516 0.1016
207 INJECTION SITE IRRITATION 1291 0.1013
208 HEPATIC CIRRHOSIS 1900 0.1010
209 LOWER LIMB FRACTURE 1935 0.1006
210 BRONCHOPULMONARY ASPERGILLOSIS 776 0.1000
211 APPARENT DEATH 356 0.0988
212 CREPITATIONS 293 0.0983
213 LUNG ADENOCARCINOMA 295 0.0979
214 NIGHT SWEATS 3147 0.0976
215 PULMONARY MASS 1450 0.0972
216 SKIN ULCER 2508 0.0969
217 INFECTION 14022 0.0968
218 HEPATOTOXICITY 2151 0.0965
219 HAEMATOTOXICITY 916 0.0963
220 IRITIS 291 0.0956
221 TENDERNESS 993 0.0952
222 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 6755 0.0949
223 ANAL FISSURE 509 0.0948
224 HERPES SIMPLEX 614 0.0944
225 APHTHOUS ULCER 721 0.0929
226 SKIN PLAQUE 783 0.0927
227 BACTERIAL SEPSIS 302 0.0926
228 HEPATIC ENZYME ABNORMAL 461 0.0923
229 PRODUCT LABEL CONFUSION 538 0.0922
230 PHARYNGITIS 1142 0.0920
231 EAR PAIN 1775 0.0912
232 DRUG TOLERANCE 457 0.0902
233 ARTHRALGIA 37220 0.0894
234 PLEURISY 529 0.0890
235 INTENTIONAL PRODUCT USE ISSUE 7793 0.0889
236 CYTOMEGALOVIRUS INFECTION 1475 0.0887
237 PERIPHERAL SWELLING 13670 0.0886
238 HEPATIC STEATOSIS 1633 0.0876
239 PYODERMA GANGRENOSUM 315 0.0875
240 THERAPY NON-RESPONDER 3911 0.0869
241 PRESCRIBED OVERDOSE 1681 0.0868
242 COELIAC DISEASE 848 0.0864
243 ABDOMINAL DISCOMFORT 14500 0.0864
244 GASTROINTESTINAL DISORDER 7709 0.0860
245 TONSILLITIS 449 0.0859
246 LUNG DISORDER 4206 0.0857
247 PNEUMONIA FUNGAL 337 0.0853
248 STAPHYLOCOCCAL BACTERAEMIA 369 0.0848
249 ULCER HAEMORRHAGE 572 0.0844
250 VIRAL UPPER RESPIRATORY TRACT INFECTION 401 0.0843
251 BONE MARROW FAILURE 1711 0.0841
252 CYTOPENIA 1030 0.0840
253 ERYTHEMA NODOSUM 295 0.0839
254 ILL-DEFINED DISORDER 5089 0.0837
255 WHEELCHAIR USER 372 0.0836
256 GASTROINTESTINAL TOXICITY 402 0.0836
257 SPINAL FUSION SURGERY 339 0.0835
258 HYPERTRIGLYCERIDAEMIA 487 0.0831
259 DRUG SPECIFIC ANTIBODY PRESENT 540 0.0829
260 LIVER DISORDER 3672 0.0827
261 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 420 0.0824
262 THROMBOTIC MICROANGIOPATHY 800 0.0820
263 CHRONIC SINUSITIS 307 0.0817
264 SPINAL OSTEOARTHRITIS 718 0.0816
265 PSORIASIS 10673 0.0816
266 DIVERTICULITIS 2253 0.0812
267 OSTEOPOROSIS 3337 0.0810
268 ABSCESS LIMB 344 0.0806
269 EAR INFECTION 2143 0.0804
270 NEUROTOXICITY 1407 0.0802
271 ULCER 1276 0.0801
272 LYMPHOMA 1239 0.0801
273 DEFORMITY 748 0.0799
274 SINUS CONGESTION 1078 0.0797
275 IMMOBILE 348 0.0796
276 TOOTH ABSCESS 811 0.0796
277 RHINOVIRUS INFECTION 309 0.0793
278 HERPES ZOSTER 4560 0.0793
279 POSTOPERATIVE WOUND INFECTION 536 0.0793
280 ANAL ABSCESS 427 0.0791
281 INTERVERTEBRAL DISC DEGENERATION 733 0.0791
282 NASOPHARYNGITIS 14598 0.0791
283 OESOPHAGEAL CANDIDIASIS 312 0.0782
284 TOOTH INFECTION 1030 0.0781
285 MENISCUS INJURY 477 0.0775
286 SKIN PAPILLOMA 311 0.0775
287 RASH VESICULAR 372 0.0769
288 ALOPECIA 15098 0.0768
289 NEUTROPENIC SEPSIS 549 0.0768
290 ANAL FISTULA 410 0.0768
291 ORAL HERPES 1494 0.0765
292 ADVERSE REACTION 1012 0.0762
293 MATERNAL EXPOSURE DURING PREGNANCY 6792 0.0761
294 LOCALISED INFECTION 1837 0.0759
295 LUNG NEOPLASM 320 0.0749
296 POOR VENOUS ACCESS 774 0.0747
297 RESPIRATORY TRACT CONGESTION 1186 0.0746
298 MUSCULOSKELETAL DISORDER 1413 0.0742
299 HEPATITIS 1895 0.0740
300 JOINT INJURY 1582 0.0740
301 HYPOGAMMAGLOBULINAEMIA 485 0.0738
302 HYPERCALCAEMIA 910 0.0736
303 RED CELL DISTRIBUTION WIDTH INCREASED 306 0.0736
304 FEAR OF INJECTION 524 0.0734
305 TIBIA FRACTURE 344 0.0733
306 MUSCLE SPASTICITY 900 0.0732
307 SPINAL PAIN 858 0.0732
308 SQUAMOUS CELL CARCINOMA 689 0.0731
309 POST PROCEDURAL INFECTION 594 0.0730
310 DRUG LEVEL BELOW THERAPEUTIC 402 0.0728
311 SUBCUTANEOUS ABSCESS 349 0.0727
312 CARPAL TUNNEL SYNDROME 1017 0.0725
313 SEPTIC SHOCK 3158 0.0725
314 ENCEPHALITIS 501 0.0723
315 ENTEROCOCCAL INFECTION 349 0.0722
316 ESCHERICHIA URINARY TRACT INFECTION 307 0.0722
317 RHINITIS 580 0.0719
318 HYPERTRANSAMINASAEMIA 497 0.0714
319 INJECTION SITE WARMTH 1465 0.0712
320 BACTERIAL INFECTION 1323 0.0708
321 NECK PAIN 3958 0.0707
322 ADRENAL INSUFFICIENCY 859 0.0707
323 CYST 877 0.0706
324 ORGANISING PNEUMONIA 350 0.0706
325 DRUG EFFECT INCOMPLETE 2564 0.0705
326 UPPER RESPIRATORY TRACT INFECTION 3261 0.0705
327 BODY TEMPERATURE INCREASED 1439 0.0705
328 DRUG ERUPTION 1248 0.0704
329 HYPERBILIRUBINAEMIA 729 0.0703
330 PRESCRIBED UNDERDOSE 1403 0.0703
331 VASCULITIS 818 0.0701
332 MYELODYSPLASTIC SYNDROME 1014 0.0700
333 TRIGGER FINGER 286 0.0699
334 DISABILITY 1384 0.0699
335 KLEBSIELLA INFECTION 353 0.0697
336 SKIN LESION 1905 0.0694
337 ROTATOR CUFF SYNDROME 882 0.0686
338 INJECTION SITE PAPULE 313 0.0683
339 CLOSTRIDIUM DIFFICILE COLITIS 720 0.0678
340 INTERSTITIAL LUNG DISEASE 3285 0.0678
341 BRONCHITIS 5013 0.0677
342 BREAST CANCER STAGE II 563 0.0676
343 ABSCESS 1077 0.0674
344 SKIN INFECTION 755 0.0672
345 CONDITION AGGRAVATED 20375 0.0669
346 GENERAL PHYSICAL HEALTH DETERIORATION 7713 0.0666
347 HYPERSENSITIVITY 12351 0.0665
348 PSEUDOMONAS INFECTION 569 0.0663
349 HERPES VIRUS INFECTION 381 0.0661
350 HYPOALBUMINAEMIA 514 0.0660
351 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 540 0.0654
352 SLEEP DISORDER 4607 0.0652
353 HEART RATE DECREASED 2279 0.0648
354 MALIGNANT MELANOMA 857 0.0639
355 DRUG-INDUCED LIVER INJURY 2005 0.0638
356 CONTUSION 6149 0.0638
357 BACTERAEMIA 758 0.0638
358 STREPTOCOCCAL INFECTION 355 0.0637
359 VAGINAL INFECTION 299 0.0635
360 INTERVERTEBRAL DISC PROTRUSION 1377 0.0629
361 OSTEOMYELITIS 1138 0.0628
362 PHARYNGOLARYNGEAL PAIN 334 0.0628
363 MYOSITIS 563 0.0627
364 APLASTIC ANAEMIA 327 0.0625
365 WHEEZING 3711 0.0625
366 INJECTION SITE REACTION 4292 0.0623
367 TENDON DISORDER 406 0.0622
368 THERAPY PARTIAL RESPONDER 971 0.0622
369 PAIN IN EXTREMITY 18315 0.0621
370 RESPIRATORY DISORDER 1852 0.0618
371 STAPHYLOCOCCAL INFECTION 2033 0.0616
372 ORAL DISORDER 451 0.0615
373 STRESS FRACTURE 330 0.0611
374 LOCAL SWELLING 1064 0.0609
375 ENTERITIS 390 0.0609
376 LEUKOPENIA 3047 0.0609
377 LIMB OPERATION 292 0.0608
378 NEPHROPATHY TOXIC 683 0.0608
379 THERAPEUTIC RESPONSE DECREASED 3687 0.0607
380 CANDIDA INFECTION 1026 0.0607
381 HYPERKERATOSIS 335 0.0607
382 CELLULITIS 3058 0.0606
383 ERYSIPELAS 304 0.0604
384 SPINAL COLUMN STENOSIS 285 0.0603
385 SPINAL DISORDER 571 0.0602
386 ACUTE MYELOID LEUKAEMIA 938 0.0601
387 GASTROINTESTINAL INFECTION 539 0.0601
388 LIVER FUNCTION TEST ABNORMAL 1746 0.0600
389 OEDEMA 3242 0.0597
390 CYSTITIS 1900 0.0596
391 ACUTE RESPIRATORY DISTRESS SYNDROME 1049 0.0593
392 RESPIRATORY TRACT INFECTION 1541 0.0591
393 PAIN 36336 0.0591
394 ARTHROPOD BITE 436 0.0588
395 TENDONITIS 910 0.0587
396 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1006 0.0586
397 LUNG INFILTRATION 517 0.0585
398 ROAD TRAFFIC ACCIDENT 2443 0.0583
399 FOOT FRACTURE 1107 0.0583
400 OSTEOPENIA 886 0.0583
401 PHARYNGITIS STREPTOCOCCAL 631 0.0582
402 PYELONEPHRITIS 504 0.0581
403 DRUG INEFFECTIVE 76410 0.0579
404 TRANSAMINASES INCREASED 1286 0.0578
405 IMMUNE SYSTEM DISORDER 762 0.0578
406 ESCHERICHIA INFECTION 474 0.0576
407 GASTROINTESTINAL INFLAMMATION 448 0.0571
408 INJECTION SITE PRURITUS 3831 0.0571
409 ORAL CANDIDIASIS 751 0.0570
410 CONGENITAL ANOMALY 441 0.0569
411 SKIN LACERATION 619 0.0569
412 SEPSIS 6334 0.0567
413 DYSLIPIDAEMIA 287 0.0565
414 FISTULA 628 0.0558
415 MENINGITIS 373 0.0558
416 NERVE COMPRESSION 512 0.0554
417 PNEUMONIA BACTERIAL 508 0.0553
418 DRUG EFFECT DECREASED 2981 0.0553
419 IMPAIRED WORK ABILITY 1171 0.0547
420 TENDON RUPTURE 675 0.0546
421 SQUAMOUS CELL CARCINOMA OF SKIN 330 0.0546
422 DIVERTICULUM 386 0.0543
423 SENSORY LOSS 437 0.0542
424 MUSCULOSKELETAL DISCOMFORT 933 0.0542
425 KIDNEY INFECTION 1061 0.0540
426 CATARACT 3218 0.0540
427 VIRAL INFECTION 1798 0.0540
428 TONGUE DISORDER 390 0.0538
429 FUNGAL INFECTION 1786 0.0535
430 GASTROENTERITIS 781 0.0535
431 INJURY 3758 0.0534
432 FREQUENT BOWEL MOVEMENTS 1443 0.0534
433 PNEUMONITIS 1453 0.0533
434 TOOTH FRACTURE 588 0.0533
435 DERMATITIS ALLERGIC 670 0.0532
436 ALANINE AMINOTRANSFERASE INCREASED 3241 0.0527
437 LUNG INFECTION 817 0.0525
438 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1488 0.0525
439 ATELECTASIS 507 0.0524
440 FURUNCLE 415 0.0523
441 HYPERTENSION 11081 0.0523
442 HEMIPARESIS 883 0.0521
443 MASS 724 0.0518
444 PNEUMONIA 16739 0.0517
445 SKIN MASS 345 0.0516
446 TUMOUR LYSIS SYNDROME 453 0.0514
447 SPUTUM DISCOLOURED 483 0.0509
448 VITAMIN D DECREASED 435 0.0508
449 WEIGHT INCREASED 11381 0.0508
450 PYREXIA 17561 0.0507
451 BONE DISORDER 922 0.0505
452 INJECTION SITE ERYTHEMA 6266 0.0505
453 LYMPHADENOPATHY 1788 0.0505
454 OROPHARYNGEAL PAIN 4675 0.0505
455 HEPATOMEGALY 496 0.0504
456 SPINAL COMPRESSION FRACTURE 417 0.0504
457 PRODUCT USE ISSUE 9460 0.0503
458 ODYNOPHAGIA 300 0.0502
459 BREAST MASS 334 0.0497
460 COVID-19 PNEUMONIA 586 0.0496
461 RENAL CYST 392 0.0493
462 PULMONARY HAEMORRHAGE 384 0.0490
463 UROSEPSIS 451 0.0488
464 LIGAMENT SPRAIN 482 0.0487
465 LYMPHOPENIA 686 0.0485
466 DRUG LEVEL DECREASED 492 0.0483
467 ARTERIAL OCCLUSIVE DISEASE 378 0.0480
468 INFLUENZA 5351 0.0479
469 EMPHYSEMA 483 0.0478
470 SECRETION DISCHARGE 599 0.0478
471 PELVIC FRACTURE 372 0.0477
472 HYPOAESTHESIA 7133 0.0476
473 EYE INFECTION 538 0.0476
474 PAPULE 335 0.0475
475 INJECTION SITE INDURATION 616 0.0475
476 GINGIVAL PAIN 376 0.0472
477 RASH PUSTULAR 344 0.0472
478 DISSEMINATED INTRAVASCULAR COAGULATION 663 0.0470
479 INCREASED TENDENCY TO BRUISE 432 0.0469
480 RASH 20465 0.0469
481 INJECTION SITE SWELLING 3586 0.0468
482 RESPIRATORY RATE INCREASED 415 0.0467
483 RHINORRHOEA 3008 0.0465
484 DECREASED IMMUNE RESPONSIVENESS 456 0.0464
485 TASTE DISORDER 940 0.0463
486 DEVICE RELATED INFECTION 713 0.0463
487 INJECTION SITE PAIN 14173 0.0462
488 TOOTH DISORDER 1026 0.0461
489 MOTOR DYSFUNCTION 470 0.0461
490 GLAUCOMA 887 0.0460
491 HEMIPLEGIA 383 0.0460
492 DIARRHOEA HAEMORRHAGIC 430 0.0460
493 WEIGHT FLUCTUATION 480 0.0458
494 HAND FRACTURE 325 0.0458
495 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2508 0.0457
496 PRODUCTIVE COUGH 2179 0.0456
497 GAIT DISTURBANCE 8722 0.0455
498 KNEE OPERATION 448 0.0455
499 MATERNAL EXPOSURE BEFORE PREGNANCY 311 0.0455
500 ENCEPHALOPATHY 1116 0.0454
501 INJECTION SITE BRUISING 3621 0.0453
502 DYSSTASIA 1320 0.0452
503 LIMB INJURY 1225 0.0451
504 NEPHROLITHIASIS 2066 0.0450
505 IRON DEFICIENCY ANAEMIA 415 0.0449
506 BACK DISORDER 731 0.0449
507 DELIRIUM 1560 0.0449
508 PHOTOSENSITIVITY REACTION 740 0.0448
509 ORAL PAIN 1003 0.0447
510 HIATUS HERNIA 579 0.0447
511 COLITIS 1695 0.0447
512 FACIAL PARALYSIS 381 0.0447
513 EPILEPSY 1365 0.0446
514 HEPATOCELLULAR INJURY 633 0.0446
515 GASTROENTERITIS VIRAL 804 0.0445
516 LIMB DISCOMFORT 1377 0.0445
517 MULTI-ORGAN FAILURE 769 0.0444
518 GASTROINTESTINAL PAIN 485 0.0440
519 THROMBOCYTOPENIA 4925 0.0440
520 POLYP 288 0.0439
521 ANKLE FRACTURE 678 0.0438
522 GROIN PAIN 384 0.0437
523 CARDIOTOXICITY 389 0.0436
524 CARDIAC MURMUR 376 0.0434
525 ASPARTATE AMINOTRANSFERASE INCREASED 2306 0.0434
526 CLOSTRIDIUM DIFFICILE INFECTION 942 0.0431
527 UTERINE LEIOMYOMA 315 0.0431
528 OXYGEN SATURATION DECREASED 2420 0.0430
529 SKIN HAEMORRHAGE 637 0.0429
530 MOUTH HAEMORRHAGE 314 0.0428
531 URTICARIA 7160 0.0427
532 DRY MOUTH 3467 0.0427
533 BLOOD IRON DECREASED 507 0.0427
534 PULMONARY THROMBOSIS 464 0.0425
535 POLYNEUROPATHY 508 0.0424
536 GASTRIC ULCER 802 0.0422
537 PREGNANCY 843 0.0421
538 NEUTROPENIA 5718 0.0420
539 INJECTION SITE DISCOLOURATION 525 0.0420
540 MYELOSUPPRESSION 1508 0.0418
541 DYSPEPSIA 4106 0.0417
542 MIGRAINE 3974 0.0416
543 EXPOSURE DURING PREGNANCY 2584 0.0415
544 BLOOD TEST ABNORMAL 584 0.0415
545 INJECTION SITE RASH 1273 0.0414
546 COLITIS ULCERATIVE 1851 0.0414
547 MUSCULAR WEAKNESS 4704 0.0413
548 OVARIAN CYST 413 0.0413
549 LARGE INTESTINE POLYP 284 0.0410
550 PRODUCT USE IN UNAPPROVED INDICATION 10158 0.0409
551 CONFUSIONAL STATE 6616 0.0409
552 SKIN CANCER 875 0.0406
553 OFF LABEL USE 35480 0.0405
554 VITAMIN D DEFICIENCY 394 0.0404
555 GASTRIC DISORDER 1386 0.0403
556 DENTAL CARIES 446 0.0403
557 SKIN REACTION 566 0.0401
558 BLOOD LACTATE DEHYDROGENASE INCREASED 636 0.0401
559 ADVERSE DRUG REACTION 3603 0.0401
560 NASAL CONGESTION 2350 0.0399
561 SCAB 456 0.0399
562 OEDEMA PERIPHERAL 4871 0.0399
563 BACK PAIN 9282 0.0399
564 COAGULOPATHY 664 0.0398
565 RESPIRATORY FAILURE 2906 0.0398
566 PLEURAL EFFUSION 2413 0.0396
567 PNEUMOTHORAX 627 0.0395
568 SINUS DISORDER 783 0.0395
569 EYE INFLAMMATION 377 0.0395
570 HEPATIC CYTOLYSIS 503 0.0394
571 SKIN DISORDER 1314 0.0394
572 INJECTION SITE EXTRAVASATION 486 0.0393
573 TOOTHACHE 713 0.0393
574 MUSCULOSKELETAL CHEST PAIN 609 0.0393
575 URINARY TRACT INFECTION 6663 0.0390
576 BLOOD ALBUMIN DECREASED 308 0.0388
577 NERVE INJURY 431 0.0387
578 THERAPEUTIC RESPONSE SHORTENED 1282 0.0386
579 PULMONARY CONGESTION 509 0.0386
580 INJECTION SITE URTICARIA 946 0.0385
581 RASH PRURITIC 2083 0.0384
582 FATIGUE 29905 0.0384
583 FEMUR FRACTURE 1188 0.0383
584 COUGH 10743 0.0383
585 DISEASE RECURRENCE 1822 0.0383
586 SPLENOMEGALY 448 0.0382
587 AORTIC ANEURYSM 290 0.0381
588 BLOOD PRESSURE INCREASED 5774 0.0377
589 PLATELET COUNT INCREASED 491 0.0376
590 WRIST FRACTURE 451 0.0376
591 APPENDICITIS 351 0.0375
592 DRUG LEVEL INCREASED 621 0.0375
593 INTESTINAL PERFORATION 421 0.0375
594 GASTRITIS 983 0.0373
595 IMPAIRED QUALITY OF LIFE 537 0.0373
596 POST PROCEDURAL COMPLICATION 717 0.0373
597 MUSCLE STRAIN 322 0.0372
598 BEDRIDDEN 488 0.0371
599 UPPER LIMB FRACTURE 739 0.0371
600 MYOPATHY 320 0.0370
601 WEIGHT DECREASED 10341 0.0370
602 HEPATIC FUNCTION ABNORMAL 1382 0.0370
603 HERNIA 710 0.0367
604 LACERATION 345 0.0366
605 HAEMATOCHEZIA 2020 0.0366
606 ABDOMINAL PAIN 8451 0.0363
607 ANAPHYLACTIC REACTION 1992 0.0360
608 SMALL INTESTINAL OBSTRUCTION 443 0.0360
609 ABDOMINAL PAIN UPPER 7388 0.0358
610 DRUG RESISTANCE 920 0.0358
611 MALAISE 15651 0.0357
612 RECTAL HAEMORRHAGE 1530 0.0356
613 WHITE BLOOD CELL COUNT INCREASED 1362 0.0355
614 INJECTION SITE HAEMORRHAGE 2832 0.0354
615 GASTROOESOPHAGEAL REFLUX DISEASE 2846 0.0353
616 PERICARDIAL EFFUSION 814 0.0352
617 PANCREATITIS 1850 0.0350
618 NEURALGIA 851 0.0350
619 CHOLELITHIASIS 1147 0.0349
620 SECOND PRIMARY MALIGNANCY 290 0.0348
621 EYE DISORDER 1146 0.0348
622 HIDRADENITIS 316 0.0346
623 MOVEMENT DISORDER 1110 0.0345
624 RIB FRACTURE 711 0.0345
625 TOOTH EXTRACTION 430 0.0345
626 PAIN IN JAW 978 0.0345
627 DIABETES MELLITUS 2625 0.0344
628 AGRANULOCYTOSIS 638 0.0343
629 HEADACHE 21476 0.0342
630 RESPIRATORY SYNCYTIAL VIRUS INFECTION 298 0.0342
631 CONJUNCTIVITIS 633 0.0341
632 FRACTURE 644 0.0340
633 HYPOPHAGIA 868 0.0339
634 SCRATCH 358 0.0339
635 AFFECT LABILITY 324 0.0336
636 ASTHMA 3805 0.0336
637 THYROID DISORDER 518 0.0336
638 CHOLECYSTITIS 400 0.0335
639 SNEEZING 749 0.0334
640 HYSTERECTOMY 289 0.0333
641 MEDICATION ERROR 1850 0.0333
642 VOMITING 15621 0.0332
643 INFLAMMATORY BOWEL DISEASE 324 0.0331
644 HYPERTENSIVE CRISIS 365 0.0328
645 ADVERSE EVENT 3023 0.0328
646 HEART RATE IRREGULAR 740 0.0327
647 DEAFNESS 856 0.0327
648 SPINAL FRACTURE 653 0.0326
649 CHEST PAIN 6029 0.0325
650 QUALITY OF LIFE DECREASED 436 0.0325
651 BRAIN OEDEMA 410 0.0324
652 BLOOD BILIRUBIN INCREASED 874 0.0323
653 FLANK PAIN 302 0.0322
654 ACCIDENT 384 0.0321
655 HAEMORRHOIDS 626 0.0321
656 SPINAL OPERATION 394 0.0320
657 PARAESTHESIA 5021 0.0319
658 ACUTE RESPIRATORY FAILURE 612 0.0318
659 CORONARY ARTERY OCCLUSION 436 0.0318
660 COLON CANCER 473 0.0317
661 COVID-19 5566 0.0317
662 SEASONAL ALLERGY 448 0.0316
663 PHOTOPHOBIA 595 0.0316
664 DRY EYE 1576 0.0315
665 EATING DISORDER 672 0.0315
666 REBOUND EFFECT 356 0.0315
667 HAEMATOCRIT DECREASED 624 0.0314
668 DERMATITIS 657 0.0313
669 ANAEMIA 5971 0.0313
670 AMNESIA 2036 0.0313
671 CHOLESTASIS 600 0.0312
672 NAUSEA 24715 0.0312
673 ANGINA PECTORIS 888 0.0310
674 DEEP VEIN THROMBOSIS 2009 0.0309
675 SLEEP APNOEA SYNDROME 589 0.0308
676 ASCITES 904 0.0307
677 MALNUTRITION 343 0.0306
678 OSTEONECROSIS 1006 0.0306
679 NEOPLASM 350 0.0304
680 OESOPHAGITIS 332 0.0304
681 DISEASE PROGRESSION 3580 0.0302
682 CHOLECYSTECTOMY 344 0.0301
683 FEELING HOT 1841 0.0300
684 PRURITUS 11533 0.0300
685 APHASIA 906 0.0300
686 PETECHIAE 311 0.0298
687 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5364 0.0297
688 INFLUENZA LIKE ILLNESS 2443 0.0297
689 GAMMA-GLUTAMYLTRANSFERASE INCREASED 656 0.0296
690 RESPIRATORY DISTRESS 816 0.0295
691 BODY HEIGHT DECREASED 315 0.0294
692 TOXIC EPIDERMAL NECROLYSIS 446 0.0293
693 MITRAL VALVE INCOMPETENCE 332 0.0293
694 SCAR 499 0.0291
695 DIARRHOEA 18807 0.0291
696 HEPATIC FAILURE 878 0.0291
697 FALL 9659 0.0290
698 ASTHENIA 10872 0.0289
699 PULMONARY EMBOLISM 2745 0.0289
700 RENAL IMPAIRMENT 2426 0.0288
701 HYPOKINESIA 419 0.0288
702 EAR DISCOMFORT 296 0.0288
703 NO THERAPEUTIC RESPONSE 350 0.0287
704 GALLBLADDER DISORDER 512 0.0287
705 OBSTRUCTIVE AIRWAYS DISORDER 316 0.0284
706 BLOOD CREATININE INCREASED 1851 0.0283
707 INJECTION SITE NODULE 311 0.0282
708 APHONIA 393 0.0281
709 CARDIOMEGALY 345 0.0280
710 TOXICITY TO VARIOUS AGENTS 4726 0.0280
711 INJECTION SITE DISCOMFORT 294 0.0279
712 SARS-COV-2 TEST POSITIVE 369 0.0279
713 ERYTHEMA 5730 0.0278
714 DRUG TOXICITY 379 0.0278
715 GOUT 498 0.0277
716 ILEUS 344 0.0277
717 RASH PAPULAR 616 0.0275
718 CHILLS 3217 0.0274
719 HYPERLIPIDAEMIA 327 0.0273
720 RASH ERYTHEMATOUS 1305 0.0273
721 PANCREATITIS ACUTE 613 0.0272
722 INSOMNIA 7262 0.0272
723 HAEMOGLOBIN DECREASED 2799 0.0272
724 MEMORY IMPAIRMENT 3743 0.0272
725 GENERALISED OEDEMA 337 0.0272
726 WHITE BLOOD CELL COUNT DECREASED 2949 0.0272
727 CARDIOMYOPATHY 402 0.0272
728 RASH MACULO-PAPULAR 603 0.0271
729 FEEDING DISORDER 549 0.0270
730 DEPRESSION 6150 0.0270
731 TACHYCARDIA 2400 0.0270
732 DECREASED APPETITE 6270 0.0270
733 NEUTROPHIL COUNT DECREASED 1095 0.0268
734 HYPOXIA 945 0.0268
735 ATRIAL FIBRILLATION 2613 0.0268
736 SKIN DISCOLOURATION 1231 0.0268
737 LABORATORY TEST ABNORMAL 789 0.0267
738 THROAT IRRITATION 1189 0.0265
739 ORAL DISCOMFORT 367 0.0264
740 METASTASES TO LUNG 305 0.0264
741 ACUTE HEPATIC FAILURE 360 0.0263
742 DYSPNOEA 14884 0.0263
743 SURGERY 1533 0.0261
744 BONE DENSITY DECREASED 819 0.0261
745 TACHYPNOEA 355 0.0261
746 ACUTE KIDNEY INJURY 3994 0.0261
747 NERVOUS SYSTEM DISORDER 813 0.0260
748 DYSPNOEA EXERTIONAL 979 0.0260
749 POOR QUALITY SLEEP 556 0.0258
750 HYPOKALAEMIA 1190 0.0258
751 ABDOMINAL DISTENSION 2669 0.0255
752 MUSCLE SPASMS 4676 0.0255
753 RED BLOOD CELL COUNT DECREASED 727 0.0254
754 DRUG INTERACTION 4016 0.0253
755 ATAXIA 297 0.0250
756 DYSPHONIA 1456 0.0249
757 INTESTINAL OBSTRUCTION 938 0.0249
758 ANOREXIA 320 0.0248
759 PAIN OF SKIN 668 0.0248
760 ILLNESS 2550 0.0247
761 LUNG NEOPLASM MALIGNANT 1014 0.0246
762 BLOOD URINE PRESENT 468 0.0246
763 HEART RATE INCREASED 2441 0.0246
764 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1285 0.0246
765 ELECTROLYTE IMBALANCE 286 0.0246
766 MACULAR DEGENERATION 293 0.0245
767 COORDINATION ABNORMAL 342 0.0245
768 PERIPHERAL COLDNESS 336 0.0244
769 PROCEDURAL PAIN 678 0.0244
770 PULMONARY OEDEMA 1094 0.0244
771 HYPOCALCAEMIA 462 0.0244
772 ABASIA 602 0.0243
773 IMPAIRED GASTRIC EMPTYING 332 0.0243
774 BLINDNESS UNILATERAL 343 0.0243
775 PHARYNGEAL OEDEMA 374 0.0243
776 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 411 0.0242
777 EPISTAXIS 1806 0.0241
778 WRONG TECHNIQUE IN DRUG USAGE PROCESS 874 0.0240
779 HYPOTHYROIDISM 766 0.0240
780 RENAL FAILURE 3179 0.0239
781 DYSARTHRIA 899 0.0239
782 GINGIVAL BLEEDING 325 0.0238
783 VISUAL IMPAIRMENT 2937 0.0237
784 LEUKOCYTOSIS 428 0.0236
785 NEUROPATHY PERIPHERAL 2245 0.0236
786 VERTIGO 1437 0.0236
787 DYSURIA 867 0.0235
788 BURNING SENSATION 1650 0.0235
789 METASTASES TO LIVER 413 0.0235
790 CYTOKINE RELEASE SYNDROME 471 0.0235
791 LYMPHOCYTE COUNT DECREASED 415 0.0235
792 FEELING COLD 652 0.0234
793 THROMBOSIS 1869 0.0232
794 SKIN FISSURES 452 0.0231
795 EJECTION FRACTION DECREASED 358 0.0230
796 RENAL DISORDER 1071 0.0230
797 PALLOR 624 0.0229
798 NEOPLASM MALIGNANT 1525 0.0228
799 INTENTIONAL DOSE OMISSION 646 0.0226
800 MUSCLE ATROPHY 287 0.0226
801 TUBULOINTERSTITIAL NEPHRITIS 423 0.0225
802 TRANSIENT ISCHAEMIC ATTACK 758 0.0224
803 CHEST DISCOMFORT 2298 0.0224
804 HAEMATURIA 767 0.0224
805 PRODUCT PRESCRIBING ERROR 533 0.0224
806 ACTIVITIES OF DAILY LIVING IMPAIRED 443 0.0224
807 BLOOD ALKALINE PHOSPHATASE INCREASED 554 0.0223
808 CEREBRAL INFARCTION 542 0.0222
809 DEVICE MALFUNCTION 1558 0.0221
810 HAEMOPTYSIS 618 0.0221
811 PRURITUS GENERALISED 476 0.0220
812 RENAL FAILURE ACUTE 934 0.0220
813 SINUS TACHYCARDIA 312 0.0220
814 RASH MACULAR 768 0.0219
815 ABDOMINAL PAIN LOWER 554 0.0219
816 DIZZINESS 10909 0.0218
817 HIP FRACTURE 702 0.0218
818 PARALYSIS 311 0.0217
819 BLOOD PRESSURE ABNORMAL 431 0.0217
820 PLATELET COUNT DECREASED 2301 0.0216
821 CORONARY ARTERY DISEASE 651 0.0215
822 ACCIDENTAL OVERDOSE 783 0.0214
823 MENTAL STATUS CHANGES 592 0.0213
824 HAEMATOMA 550 0.0212
825 BLOOD TRIGLYCERIDES INCREASED 372 0.0210
826 HYPOTENSION 4223 0.0210
827 SHOCK 482 0.0209
828 CARDIAC FAILURE 1680 0.0209
829 BONE PAIN 1224 0.0209
830 DYSPHAGIA 1972 0.0208
831 DIPLOPIA 538 0.0207
832 SWELLING FACE 1347 0.0207
833 PROTEINURIA 388 0.0204
834 SWOLLEN TONGUE 637 0.0204
835 SUBDURAL HAEMATOMA 289 0.0202
836 SENSORY DISTURBANCE 324 0.0202
837 EOSINOPHILIA 353 0.0201
838 BLOOD PRESSURE DECREASED 1330 0.0200
839 FLUID RETENTION 1018 0.0200
840 ACUTE MYOCARDIAL INFARCTION 587 0.0199
841 PERITONITIS 412 0.0199
842 PULMONARY HYPERTENSION 414 0.0199
843 SKIN EXFOLIATION 1674 0.0198
844 MYALGIA 3355 0.0197
845 URINARY INCONTINENCE 584 0.0197
846 BLOOD UREA INCREASED 329 0.0196
847 MULTIPLE FRACTURES 321 0.0195
848 LOSS OF CONSCIOUSNESS 2498 0.0195
849 EYE PAIN 1095 0.0194
850 LACRIMATION INCREASED 586 0.0194
851 HAEMORRHAGE 2022 0.0193
852 HYPERGLYCAEMIA 704 0.0193
853 BREAST CANCER 1795 0.0192
854 BLOOD POTASSIUM DECREASED 579 0.0192
855 HAEMORRHAGE INTRACRANIAL 286 0.0191
856 TINNITUS 877 0.0191
857 OSTEONECROSIS OF JAW 472 0.0191
858 HAEMATEMESIS 478 0.0188
859 UNDERDOSE 1369 0.0187
860 HEAD DISCOMFORT 331 0.0187
861 DEVICE ISSUE 1657 0.0185
862 BLINDNESS 746 0.0183
863 FEELING ABNORMAL 4376 0.0182
864 JAUNDICE 488 0.0181
865 ANXIETY 5155 0.0181
866 LETHARGY 1041 0.0181
867 PRESYNCOPE 437 0.0180
868 MIDDLE INSOMNIA 334 0.0179
869 PRODUCT PRESCRIBING ISSUE 388 0.0178
870 HEAD INJURY 562 0.0177
871 PALPITATIONS 2075 0.0177
872 COLD SWEAT 311 0.0176
873 UNEVALUABLE EVENT 1334 0.0176
874 ARRHYTHMIA 827 0.0174
875 HYPERHIDROSIS 2243 0.0174
876 THROAT TIGHTNESS 470 0.0174
877 INJECTION SITE MASS 642 0.0173
878 ECZEMA 907 0.0173
879 SYNCOPE 1734 0.0173
880 NEEDLE ISSUE 500 0.0172
881 ANAPHYLACTIC SHOCK 440 0.0170
882 INCORRECT DOSE ADMINISTERED 3875 0.0170
883 BLOOD SODIUM DECREASED 317 0.0168
884 RASH GENERALISED 435 0.0168
885 RESTLESS LEGS SYNDROME 304 0.0167
886 DEHYDRATION 2229 0.0167
887 GASTROINTESTINAL HAEMORRHAGE 1386 0.0166
888 CEREBRAL HAEMORRHAGE 588 0.0164
889 MELAENA 359 0.0163
890 ISCHAEMIC STROKE 290 0.0162
891 POLLAKIURIA 672 0.0161
892 OCULAR HYPERAEMIA 764 0.0161
893 MYOCARDIAL INFARCTION 2796 0.0160
894 FAECES DISCOLOURED 346 0.0159
895 DEPRESSED MOOD 830 0.0157
896 HYPERSOMNIA 448 0.0156
897 DRUG DOSE OMISSION 2560 0.0155
898 VISUAL ACUITY REDUCED 514 0.0155
899 HYPONATRAEMIA 870 0.0154
900 TREATMENT NONCOMPLIANCE 839 0.0153
901 SPEECH DISORDER 797 0.0152
902 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1081 0.0152
903 CRYING 549 0.0151
904 CEREBROVASCULAR ACCIDENT 2558 0.0151
905 CARDIAC FAILURE CONGESTIVE 1209 0.0150
906 EYE SWELLING 559 0.0150
907 HOT FLUSH 1130 0.0150
908 NERVOUSNESS 781 0.0149
909 TOOTH LOSS 308 0.0148
910 BALANCE DISORDER 1284 0.0148
911 PNEUMONIA ASPIRATION 368 0.0147
912 LIP SWELLING 485 0.0145
913 CARDIAC DISORDER 1359 0.0145
914 THERAPY CESSATION 739 0.0144
915 URINARY RETENTION 480 0.0144
916 SEIZURE 1658 0.0143
917 CONVULSION 820 0.0143
918 HYPOACUSIS 616 0.0143
919 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 419 0.0143
920 METABOLIC ACIDOSIS 453 0.0142
921 CARDIOVASCULAR DISORDER 352 0.0139
922 VISION BLURRED 1884 0.0137
923 FLATULENCE 773 0.0136
924 ACNE 1032 0.0136
925 PRODUCT DOSE OMISSION 887 0.0136
926 STEVENS-JOHNSON SYNDROME 302 0.0136
927 BLOOD CREATINE PHOSPHOKINASE INCREASED 391 0.0136
928 SOMNOLENCE 2734 0.0136
929 ALTERED STATE OF CONSCIOUSNESS 294 0.0136
930 THERAPY INTERRUPTED 966 0.0135
931 INTENTIONAL PRODUCT MISUSE 1170 0.0134
932 DISORIENTATION 527 0.0133
933 CARDIAC ARREST 1092 0.0132
934 THERAPEUTIC RESPONSE UNEXPECTED 588 0.0131
935 COMA 624 0.0131
936 EYE PRURITUS 433 0.0129
937 MENTAL DISORDER 560 0.0129
938 PRODUCT DOSE OMISSION IN ERROR 362 0.0128
939 ANGIOEDEMA 563 0.0127
940 TREMOR 2107 0.0127
941 PRODUCT AVAILABILITY ISSUE 285 0.0125
942 CONSTIPATION 2708 0.0124
943 PANIC ATTACK 443 0.0121
944 CHRONIC KIDNEY DISEASE 918 0.0121
945 DEMENTIA 335 0.0120
946 EMOTIONAL DISORDER 367 0.0119
947 ABORTION SPONTANEOUS 476 0.0119
948 FLUSHING 1203 0.0118
949 UNRESPONSIVE TO STIMULI 304 0.0118
950 CARDIO-RESPIRATORY ARREST 492 0.0118
951 COGNITIVE DISORDER 547 0.0117
952 MALIGNANT NEOPLASM PROGRESSION 1199 0.0117
953 DEPRESSED LEVEL OF CONSCIOUSNESS 459 0.0116
954 NEOPLASM PROGRESSION 403 0.0116
955 BREAST CANCER FEMALE 307 0.0115
956 HYPOGLYCAEMIA 546 0.0112
957 PRODUCT DOSE OMISSION ISSUE 3300 0.0112
958 FEAR 292 0.0108
959 DYSGEUSIA 805 0.0108
960 VAGINAL HAEMORRHAGE 467 0.0107
961 FOETAL EXPOSURE DURING PREGNANCY 854 0.0105
962 MOOD SWINGS 326 0.0102
963 DRY SKIN 1351 0.0101
964 HOSPITALISATION 1539 0.0100
965 BRADYCARDIA 529 0.0100
966 DISTURBANCE IN ATTENTION 518 0.0096
967 EYE IRRITATION 552 0.0096
968 SUICIDAL IDEATION 869 0.0095
969 PROSTATE CANCER 760 0.0094
970 MULTIPLE SCLEROSIS 437 0.0091
971 IRRITABILITY 545 0.0091
972 PRODUCT QUALITY ISSUE 1209 0.0089
973 NIGHTMARE 295 0.0085
974 ACCIDENTAL EXPOSURE TO PRODUCT 872 0.0085
975 OVERDOSE 1808 0.0084
976 DYSKINESIA 334 0.0082
977 BLOOD GLUCOSE INCREASED 1540 0.0082
978 AGITATION 558 0.0076
979 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1513 0.0075
980 BLOOD GLUCOSE DECREASED 329 0.0068
981 SKIN BURNING SENSATION 489 0.0068
982 SKIN IRRITATION 307 0.0067
983 PRODUCT STORAGE ERROR 580 0.0066
984 DEVICE LEAKAGE 287 0.0066
985 HALLUCINATION 470 0.0062
986 NO ADVERSE EVENT 1110 0.0061
987 DEATH 5106 0.0059
988 BLADDER CANCER 330 0.0056
989 SUICIDE ATTEMPT 336 0.0055
990 EMOTIONAL DISTRESS 596 0.0049
991 DRUG DEPENDENCE 564 0.0035